The research find something new about CML leukemia life expectancy. CML patients (chronic myeloid leukemia) is now can have a normal life expectancy for those who respond to initial treatment with imatinib (Gleevec).
Imatinib has proven to inhibit the progression of CML, allowing the majority of patients (65–75%) to have a regrowth of their normal bone marrow. Although few leukemic cells persist in most patient’s blood cells,the superiority of imatinib advised to developed to produce better drugs.
Recent year before the advent of imatinib, bone marrow transplantation was also used as initial treatment for CML, despite is now rarely used as a high rate of transplant-related mortality.
The new findings CML leukemia life expectancy was warmly enthusiastic researchers. Carlo Gambacorti-Passerini, MD, of the University of Milano Bicocca Italy, argues The finding is an “indication of how profoundly imatinib has changed the clinical course” of the disease“.
While B. Douglas Smith, MD, of the Sidney Kimmel Comprehensive Cancer Center in Baltimore argued “we can entertain the possibility of curing” the disease without a stem cell transplant.
CML (Chronic Myelogenous Leukemia) Symptoms
Chronic myelogenous leukemia is a rare type of leukemia (blood cancer) that commonly due to a gene abnormality that tends to affect older males.
An important notice is the early symptoms of chronic myeloid leukemia can include fever without infection, sweating, chills, and fatigue.
Then further symptoms of CML are :
- Losing weight without diet and workout
- Decreased appetite
- Easy bleeding
- Pain or fullness below the ribs on the left side
It’s important to you to make an appointment with your doctor immediately if you have signs or symptoms that bother you. During the early phase CML doesn’t always indicate obvious signs and symptoms. The interesting CML leukemia facts is it’s possible to One live with CML for months without realizing it.
If you are diagnosed with Chronic Myelogenous Leukemia, you’ve already know to request immediately treatment with imatinib in order to increase the chances to have a normal CML leukemia life expectancy.